The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

Detalles Bibliográficos
Autores principales: Isaksen, Kathrine T., Beiske, Klaus, Smeland, Erlend B., Jørgensen, Judit, Brodtkorb, Marianne, Myklebust, June Helen, Jerkeman, Mats, Meriranta, Leo, Karjalainen‐Lindsberg, Marja‐Liisa, Leppä, Sirpa, Scott, David W., Holte, Harald, Blaker, Yngvild Nuvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175840/
https://www.ncbi.nlm.nih.gov/pubmed/35846101
http://dx.doi.org/10.1002/jha2.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175840/
https://www.ncbi.nlm.nih.gov/pubmed/35846101
http://dx.doi.org/10.1002/jha2.109

Ejemplares similares